Reviewing Orthofix International N.V. (OFIX) and Its Rivals
Orthofix International N.V. (NASDAQ: OFIX) is one of 84 publicly-traded companies in the “Medical Equipment, Supplies & Distribution” industry, but how does it contrast to its peers? We will compare Orthofix International N.V. to related businesses based on the strength of its earnings, dividends, risk, analyst recommendations, institutional ownership, profitability and valuation.
This is a summary of current recommendations for Orthofix International N.V. and its peers, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Orthofix International N.V.||0||0||5||0||3.00|
|Orthofix International N.V. Competitors||168||1115||2455||89||2.64|
Insider and Institutional Ownership
94.4% of Orthofix International N.V. shares are owned by institutional investors. Comparatively, 63.1% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by institutional investors. 5.6% of Orthofix International N.V. shares are owned by company insiders. Comparatively, 12.9% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
This table compares Orthofix International N.V. and its peers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Orthofix International N.V.||1.88%||9.96%||7.32%|
|Orthofix International N.V. Competitors||-127.08%||-36.39%||-10.24%|
Valuation & Earnings
This table compares Orthofix International N.V. and its peers top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||EBITDA||Price/Earnings Ratio|
|Orthofix International N.V.||$418.71 million||$45.74 million||116.71|
|Orthofix International N.V. Competitors||$827.23 million||$159.49 million||36.42|
Orthofix International N.V.’s peers have higher revenue and earnings than Orthofix International N.V.. Orthofix International N.V. is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.
Volatility and Risk
Orthofix International N.V. has a beta of 0.2, indicating that its stock price is 80% less volatile than the S&P 500. Comparatively, Orthofix International N.V.’s peers have a beta of 1.06, indicating that their average stock price is 6% more volatile than the S&P 500.
Orthofix International N.V. beats its peers on 7 of the 13 factors compared.
Orthofix International N.V. Company Profile
Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim. The Biologics products include AlloQuent Structural Allografts, Trinity ELITE, Trinity Evolution and VersaShield. The Extremity Fixation products include Fixator, Eight-Plate Guided Growth System and Contours VPS Volar Plating System III. The Spine Fixation products include Hallmark Anterior Cervical Plate System, Ascent LE Posterior Occipital Cervico-Thoracic (POCT) System, Firebird Deformity Correction System, Phoenix Minimally Invasive Spinal Fixation System, Samba-Screw System, LONESTAR Cervical Stand Alone (CSA), SKYHAWK Lateral Interbody Fusion System & Lateral Plate System and CENTURION POCT System.
Receive News & Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related companies with MarketBeat.com's FREE daily email newsletter.